The U.S. pharmaceutical supply chain uses advanced serialization and electronic tracking to prevent counterfeit drugs from reaching patients. Since the DSCSA was enacted in 2013, counterfeit incidents have dropped by 63%, thanks to unique barcodes, real-time verification, and strict partner verification.